BioCentriq, the New Jersey Innovation Institute’s cell and gene therapy development and manufacturing center, is partnering with Kytopen, a Cambridge-based startup spun out of Massachusetts Institute of Technology (MIT).   “Our mission at BioCentriq is to work with innovative industry partners like Kytopen to advance the production and manufacturing of cell and gene therapies, making them accessible and affordable for the patients who so desperately need them,” said Haro Hartounian, Ph.D. and ...